Tactical Therapeutics, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNew York, NY
US patents8
SAM.gov UEIL1ELDWW9KUL3
CAGE code4WAR4
Incorporated inDE
- therapies
- patented therapeutic platform
- lead compound
- Carboxyamidotriazole Orotate
- calcium signaling pathways
- solid tumors
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationMinority Owned BusinessWoman Owned BusinessWoman Owned Small Business
Self-certified by the company in its SAM.gov registration
Patents
8 US patents granted 2010–2022, 1 of them in the five years to SEP 2025.
Pharmaceuticals 6Biotechnology 1Organic fine chemistry 1
- Methods and compositions for treating SARS-CoV-2 infection using carboxyamidotriazole orotateUS 11,318,118 · granted MAY 3, 2022
- Methods and molecular pharmacodynamic biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotateUS 10,378,059 · granted AUG 13, 2019
- Compositions for treating cancers having acquired resitance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotateUS 9,089,570 · granted JUL 28, 2015
- Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazoles orotate formulationsUS 8,912,223 · granted DEC 16, 2014
- Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotateUS 8,877,785 · granted NOV 4, 2014
Newest 5 shown · Granted to Tactical Therapeutics INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Tactical Therapeutics, INC | New York | NY | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.